Âé¶¹´«Ã½

Triumph of tamoxifen

27 May 2000

Deaths from breast cancer in Britain and the US have fallen by a quarter
since the late 1980s, report Oxford University epidemiologists in The
Lancet (vol 355, p 1822). The success is put down to earlier detection,
more prompt surgery and the use of hormonal drugs such as tamoxifen. But many
other countries are failing to use tamoxifen widely enough, according to
Christina Davies, one of the team.

Sign up to our weekly newsletter

Receive a weekly dose of discovery in your inbox. We'll also keep you up to date with Âé¶¹´«Ã½ events and special offers.

Sign up

To continue reading, today with our introductory offers

or

Existing subscribers

Sign in to your account
Piano Exit Overlay Banner Mobile Piano Exit Overlay Banner Desktop